SR One Capital Management, LP
An institutional investment manager in Redwood City, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 12, 2026. SEC CIK 1910264.
- Reported value$1.04bn
- Positions15
Holdings: 15 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Veradermics, Inc.MANE | Common Stock | 922967104 | 295 | 28.4% | 2,401,868 | Unchanged | |
| Zenas BioPharma, IncZBIO | Common Stock | 98937L105 | 128 | 12.3% | 5,037,854 | Unchanged | |
| CRISPR Therapeutics AG | Common Shares | H17182108 | 111 | 10.7% | 2,038,763 | Unchanged | |
| Avalyn Pharma, IncAVLN | Common Stock | 05348Y105 | 109 | 10.5% | 3,308,649 | New+3,308,649 | |
| Design Therapeutics, Inc.DSGN | Common Stock | 25056L103 | 94.4 | 9.1% | 6,526,476 | Unchanged | |
| Odyssey Therapeutics, Inc.ODTX | Common Stock | 67613T104 | 71.0 | 6.8% | 3,794,883 | New+3,794,883 | |
| Alumis Inc.ALMS | Common Stock | 022307102 | 55.2 | 5.3% | 1,959,896 | Unchanged | |
| ORIC Pharmaceuticals, Inc.ORIC | Common Stock | 68622P109 | 50.0 | 4.8% | 4,615,384 | Added+100,455 | |
| Mineralys Therapeutics Inc.MLYS | Common Stock | 603170101 | 42.2 | 4.1% | 1,563,966 | Unchanged | |
| ARS Pharmaceuticals, Inc.SPRY | Common Stock | 82835W108 | 32.1 | 3.1% | 4,012,903 | Unchanged | |
| Mobia Medical, IncMOBI | Common Stock | 60705V103 | 26.6 | 2.6% | 1,986,072 | New+1,986,072 | |
| Nkarta, Inc.NKTX | Common Stock | 65487U108 | 9.4 | 0.9% | 3,333,333 | Unchanged | |
| Oculis Holding AG | Ordinary Shares | H5870P102 | 8.9 | 0.9% | 641,022 | Unchanged | |
| Ultragenyx Pharmaceutical Inc.RARE | Common Stock | 90400D108 | 4.6 | 0.4% | 137,753 | Unchanged | |
| enGene Holdings Inc. | Common Shares | 29286M105 | 1.3 | 0.1% | 747,750 | Unchanged |
Sold out: 2 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. | Common Stock | 03940C100 | 0.0 | 0.0% | 0 | Sold out−2,346,630 | |
| Oruka Therapeutics, IncORKA | Common Stock | 687604108 | 0.0 | 0.0% | 0 | Sold out−430,330 |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-347065 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.